M6a is involved in neuron development and synapse formation and plasticity [62], and it was also recently proposed as a gene target in various neuropsychiatric disorders where it could also be used as a biomarker [63] of schizophrenia and depression disorder comorbidity. Here, GPM6A is linked to depressive disorder.